Ropes & Gray represented Blackstone Life Sciences in the transaction. Blackstone Life Sciences (NYSE:BX) (“Blackstone”) announced a collaboration with Moderna, Inc. (NASDAQ: MRNA, “Moderna”) through a development and...
Blackstone Life Sciences’ $750 Million Collaboration with Moderna
Intrinsic Medicine’s Business Combination Agreement with Phoenix Biotech Acquisition Corp.
Ropes & Gray advised Intrinsic, while Goodwin Procter advised PBAX on the deal. Intrinsic Medicine, Inc., a therapeutics company leveraging human milk biology to transform Gut-Brain...
IDRx’s $122 Million Series A Financing
Ropes & Gray advised IDRx on the deal. Clinical stage precision cancer biopharmaceutical company IDRx announced licensing transactions with Germany-based Merck KGaA and Blueprint Medicines to...
ConvaTec Group’s Acquisition of Triad Life Sciences
Ropes & Gray represented ConvaTec Group in the transaction. ConvaTec Group, a global medical solutions company, executed its acquisition of medical device company, Triad Life Sciences. ...
Blackstone Life Sciences’ $250 Million Investment in Cellex Group
Noerr and Morgan, Lewis & Bockius advised Cellex Cell Professionals GmbH on the deal. Ropes & Gray advised Blackstone Life Sciences. The Dresden-based Cellex Group announced...